甲暴露会通过激活上皮细胞中的AhR-GDF15通路而加剧喘中的气道重塑
Cuiting Shan1, Wenguan Li1, Yipeng Sun1
1Department of Respiratory Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Environmental pollution (Barking, Essex : 1987)
|December 19, 2025
概括
酸甲 (BaP) 通过激活酸碳化合物受体 (AhR),增加生长分化因子15 (GDF15),使喘气道重塑恶化. 这种污染物诱导的途径突出显示了喘的潜在治疗标.
科学领域:
- 环境健康 环境健康
- 肺部医学 肺部医学
- 分子生物学分子生物学
背景情况:
- 气道改造,以纤维细胞激活和原沉积为特征,是喘的核心.
- 酸甲 (BaP) 是一种污染物和酸受体 (AhR) 激活剂,与严重的喘有关,但其对呼吸道重塑的影响尚未完全理解.
研究的目的:
- 调查BaP是否通过通过AhR介导的途径增强上皮质-纤维细胞交叉增强气道重塑,从而加剧气道重塑.
- 为了确定参与BaP诱导的气道改造的关键分子媒介.
主要方法:
- 研究了BaP对气道上皮细胞中GDF15表达的影响,评估了AhR与GDF15促进体的结合.
- 评估了BaP治疗细胞中的条件介质对纤维细胞激活 (α-SMA,COL1A1) 和GDF15的作用的影响.
- 在体内评估BaP对过敏原诱导的气道改造的影响,包括原沉积和介质表达.
- 研究了表甲基酸盐 (EGCG) 对AhR和BaP诱导的重塑的影响.
主要成果:
- 在依赖AhR的方式上,BaP上调了表皮GDF15的表达和分泌.
- BaP受条件的介质促进了纤维细胞激活,GDF15敲击减弱了纤维细胞激活.
- 在体内,BaP恶化了过敏原诱导的气道改造,增加了原蛋白,GDF15,α-SMA和COL1A1.1.
- 重组GDF15激活了肺纤维细胞和原蛋白的生产.
- 在体内,EGCG抑制了BaP诱导的GDF15表达和气道重塑.
结论:
- BaP通过由AhR-GDF15轴介导的上皮细胞纤维细胞交叉声加剧了气道重塑.
- 这一途径代表了由环境污染物加剧喘的潜在治疗标.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K


